UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of August 2026
Commission
File Number: 001-42762
Dreamland
Limited
(Exact
name of registrant as specified in its charter)
RM
18E, Billion Plaza Phase 2
10 Cheung Yue Street, Cheung Sha Wan, Hong Kong
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Disclosure
of Share Transfer Between Shareholder and Chief Executive Officer
On
August 11, 2026, Dreamland Limited, an exempted company incorporated under the laws of the Cayman Islands (the “Company”),
was notified that Imperial Vision Fund SPC Series 1 SP (the “Seller”) and Ms. Seto Wai Yue (the “Purchaser”),
who serves as the Company’s Chief Executive Officer, a member of the Board of Directors, and a major shareholder of the Company,
entered into a Sale and Purchase Agreement (the “SPA”), dated as of August 6, 2026, pursuant to which the Seller agreed
to sell, assign, transfer, and deliver to the Purchaser, and the Purchaser agreed to purchase and acquire from the Seller, an aggregate
of 320,000 Class A ordinary shares of the Company, par value US$0.00125 per share (the “Sale Shares”), at a purchase
price of US$3.75 per share, for an aggregate purchase price of US$1,200,000 (the “Transaction”).
Prior
to the Transaction, the Purchaser beneficially owned 749,890 Class A ordinary shares of the Company, representing approximately 22.01%
of the Company’s outstanding Class A ordinary shares. Following the consummation of the Transaction, the Purchaser beneficially
owns 1,069,890 Class A ordinary shares of the Company, representing approximately 31.42% of the Company’s outstanding Class A ordinary
shares. The foregoing percentages are based on 3,405,583 Class A ordinary shares of the Company outstanding as of August 6, 2026.
The
SPA contains customary representations, warranties and agreements by the Seller and the Purchaser, customary conditions to closing, and
other obligations of the parties. The closing of the Transaction occurred on August 6, 2026, following satisfaction or waiver of the
applicable closing conditions under the SPA.
The
Sale Shares were originally issued by the Company to the Seller in a private placement pursuant to Regulation S under the Securities
Act of 1933, as amended. The Company is not a party to the SPA, is not issuing or selling any securities pursuant thereto, and is not
receiving any proceeds from the sale of the Sale Shares. The Company has been informed of the Transaction and, subject to satisfaction
of applicable legal, regulatory, Company policy and transfer agent requirements, expects to take customary actions necessary to reflect
the transfer of the Sale Shares in the Company’s records or with its transfer agent.
The
Transaction constitutes a related-party transaction by virtue of the Purchaser’s positions as Chief Executive Officer, director,
and major shareholder of the Company. The Company’s Board of Directors has reviewed and acknowledged the Transaction in accordance
with the Company’s related-party transaction policy and corporate governance guidelines.
The
foregoing summary of the terms of the SPA does not purport to be complete and is qualified in its entirety by the full text of the SPA,
a copy of which is furnished as Exhibit 99.1 to this Report on Form 6-K and incorporated herein by reference.
Information
Contained in This Report on Form 6-K
The
information contained in this Report on Form 6-K, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration
statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in
such filing.
EXHIBIT
INDEX
| Exhibit
No. |
|
Description |
| 99.1* |
|
Sale and Purchase Agreement, dated August 6, 2026, by and between Imperial Vision Fund SPC Series 1 SP and Ms. Seto Wai Yue |
*
Certain personally identifiable information and other information has been omitted from the exhibit pursuant to Item 601(a)(6) of Regulation
S-K. The registrant hereby undertakes to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission
upon request.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
| |
Dreamland
Limited |
| Date:
August 11, 2026 |
|
|
| |
By: |
/s/
Lee Wai Kit |
| |
Name:
|
Lee
Wai Kit |
| |
Title: |
Chief
Financial Officer |